8-K: Coeptis Therapeutics to Merge with Z Squared, Creating Dogecoin Mining Giant

Coeptis Therapeutics is set to merge with Z Squared, a Dogecoin mining company, while spinning out its biopharmaceutical operations.

Summary

• Coeptis Therapeutics Holdings, Inc. has entered into a definitive merger agreement with Z Squared, Inc., a Dogecoin mining company.
• The merger will result in Z Squared becoming a wholly-owned subsidiary of Coeptis.
• Holders of Z Squared shares will receive equity in Coeptis in exchange for 9,000 U.S. based dogecoin mining machines at closing.
• The merger is subject to customary closing conditions, including regulatory approvals, Nasdaq listing, and shareholder approval from both companies.
• Coeptis intends to spin out its biopharmaceutical operations in connection with the merger.
• The transaction is anticipated to close in the third quarter of 2025.
• Coeptis will be rebranded as Z Squared, Inc. and is expected to list on the Nasdaq Capital Market.
• The combined company will focus on Dogecoin mining and other digital assets.
• Z Squared executives, David Halabu and Michelle Burke, will lead the surviving entity.
• Current Coeptis CEO, Dave Mehalick, will exit from the Board of Directors upon closing.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The merger is presented as a strategic move to capitalize on the Dogecoin market, but the success depends on market conditions and regulatory approvals. The spin-out of the biopharmaceutical operations adds a layer of complexity but is framed as a positive for shareholders.

Positives

• The merger creates a focused exposure to a DOGE asset with over $20B in market capitalization.
• The combined company will be led by experienced executives in the digital asset mining industry.
• Coeptis shareholders will have the opportunity to participate in the Dogecoin market space.
• The spin-out allows Coeptis to continue its biopharmaceutical operations separately.

Negatives

• Dave Mehalick, the current Coeptis CEO, will exit from the Board of Directors upon closing.

Risks

• The merger is subject to customary closing conditions, including regulatory and shareholder approvals.
• The continued listing on Nasdaq is a condition of closing.
• The success of the combined company depends on the volatile Dogecoin market.

Future Outlook

The combined company will focus on advancing Z Squared's digital asset mining expertise, primarily generating Dogecoin (DOGE), and is expected to list on the Nasdaq Capital Market.

Management Comments

• David Halabu stated the goal of creating the largest publicly-traded company in the United States primarily focused on DOGE mining.
• Dave Mehalick expressed excitement about bringing the opportunity to shareholders to become involved in the Dogecoin market space, while remaining involved in biopharmaceutical operations.

Industry Context

This announcement reflects a growing trend of companies seeking exposure to the cryptocurrency market through mergers and acquisitions. It also highlights the increasing interest in Dogecoin, despite its origins as a meme coin.

Comparison to Industry Standards

• It is difficult to compare this merger to industry standards as there are few publicly traded companies primarily focused on Dogecoin mining.
• Comparisons could be made to companies involved in Bitcoin mining, such as Marathon Digital Holdings or Riot Blockchain, but these companies focus on a different cryptocurrency.
• The success of this venture will depend on the efficiency of Z Squared's mining operations and the price fluctuations of Dogecoin.

Management Changes

Stakeholder Impact

• Shareholders of Coeptis will gain exposure to the Dogecoin market.
• Employees of Coeptis' biopharmaceutical division may be affected by the spin-out.
• The merger could create new opportunities for investors interested in the cryptocurrency market.

Next Steps

• Obtain regulatory approvals.
• Secure shareholder approval from both Coeptis and Z Squared.
• Complete the spin-out of Coeptis' biopharmaceutical operations.
• Rebrand Coeptis as Z Squared, Inc.
• List the combined company on the Nasdaq Capital Market.

Key Dates

Keywords

Dogecoin, mining, merger, Coeptis, Squared, biopharmaceutical, digital assets, acquisition